Compliance
Peptide marketing compliance: claims you can and can't make
For a defensible peptide business, marketing is B2B professional education — not consumer demand generation. Here is the allowed/prohibited list, grounded in FTC substantiation rules.
Peptide Merchant Services — Compliance
Peptide marketing compliance: claims you can and can't make
For a defensible peptide business, marketing is B2B professional education — not consumer demand generation. Here is the allowed/prohibited list, grounded in FTC substantiation rules.
Updated June 6, 2026 · 6 min read · https://peptidemerchantadvocates.com/resources/peptide-marketing-compliance
The short answer
Compliant peptide marketing is B2B professional education with no therapeutic, performance, or disease claims. The FTC says health-benefit claims generally require competent and reliable scientific evidence — typically randomized controlled human trials. No "fat loss," "anti-aging," "muscle growth," "same as Ozempic," before/after photos, testimonials, influencer codes, or affiliate funnels.
What marketing IS allowed?
For a defensible business, marketing should be professional, factual, and counsel-reviewed:
- Accurate product ordering information.
- Storage and handling instructions.
- FDA-approved labeling for approved drugs.
- 503B product facts without unsubstantiated efficacy claims.
- Medical education reviewed by counsel.
- Peer-reviewed literature summaries with balanced risk discussion.
- Statements of legal status — and nothing beyond it.
What marketing is prohibited?
These claims turn a product into an unapproved-drug marketing problem:
- Therapeutic and performance claims: "anti-aging," "fat loss," "muscle growth," "injury healing," "gut healing," "libido," "cognitive enhancement," "fertility optimization," "inflammation reduction."
- Lifestyle framing: "biohacking," "regenerative peptide stack."
- Equivalence claims: "same as Ozempic," "generic Mounjaro," "FDA-approved ingredients."
- "Clinically proven" without competent and reliable scientific evidence.
- Before/after photos, patient testimonials, influencer codes, and affiliate funnels.
What does the FTC actually require?
The FTC's health-products guidance says health-benefit claims generally require competent and reliable scientific evidence, and that randomized controlled human clinical testing is generally the type of substantiation experts would require. In practice, if you do not have that level of evidence for a specific claim, you cannot make the claim.
This is why testimonials and before/after photos are so dangerous: they communicate a health-benefit claim without the substantiation the FTC expects, and they are exactly the consumer-marketing signals that get accounts flagged.
Key takeaways
- Market to professionals with facts, not to consumers with benefits.
- No therapeutic, performance, anti-aging, weight-loss, or equivalence claims.
- The FTC generally requires competent, reliable scientific evidence — usually RCTs — for health claims.
- No testimonials, before/after photos, influencer codes, or affiliate funnels.
Frequently asked questions
What claims can a peptide company make in its marketing?
Accurate ordering, storage, and legal-status information; FDA-approved labeling; counsel-reviewed medical education; and balanced literature summaries. No therapeutic, performance, or equivalence claims.
Can I use customer testimonials or before/after photos for peptides?
No. Those communicate health-benefit claims without the substantiation the FTC requires, and they are classic consumer-marketing signals that get merchant accounts flagged.
What evidence does the FTC require for a health claim?
The FTC says health-benefit claims generally require competent and reliable scientific evidence, and that randomized controlled human clinical testing is generally the substantiation experts would require.
Can I say a compounded peptide is the "same as" a branded drug?
No. Equivalence claims like "same as Ozempic" or "FDA-approved ingredients" are prohibited in a defensible model.
Related compliance resources
More guidance on staying compliant and keeping payment processing in place.
- 10 things to know when selling BPC-157BPC-157 is one of the most searched peptides and one of the hardest to sell lawfully. Ten things every seller should understand about its regulatory status, marketing limits, and payment acceptance. 9 min read
- How to not get your peptide merchant account shut downA step-by-step operating playbook to keep a peptide merchant account boarded: what triggers a shutdown, the controls that prevent it, and the warning signs that mean you have days, not months. 10 min read
- How to legally run a peptide company in 2026A plain-English operating model for a defensible peptide business: lawful product pathways, the right entity, restricted marketing, and an examiner-ready payments file. 9 min read
- Is it legal to sell peptides? The four lawful pathwaysSelling peptides is legal only inside one of four FDA pathways. Here is what each one (FDA-approved, 503B, 503A, and research/IND) requires — and what falls outside the law. 8 min read
- 503A vs 503B for peptides: which compounding pathway fits?The difference between 503A and 503B decides whether you can sell office stock, who can be the seller, and what you can compound. Here is the practical breakdown for peptides. 7 min read
- Why "research use only" peptides can't be sold for human useSelling RUO or "not for human consumption" peptides into the physician-to-patient channel is one of the highest-risk models in the industry. Here is why — and what the FDA has said. 6 min read
This article is general educational information about regulatory frameworks (FDA, FTC, 503A/503B, DSCSA), not legal advice. Peptide compliance turns on product-specific and state-specific facts — review your model with qualified FDA, healthcare, and payments counsel before acting.
Keep reading
9 min read
How to legally run a peptide company in 2026
A plain-English operating model for a defensible peptide business: lawful product pathways, the right entity, restricted marketing, and an examiner-ready payments file.
8 min read
Is it legal to sell peptides? The four lawful pathways
Selling peptides is legal only inside one of four FDA pathways. Here is what each one (FDA-approved, 503B, 503A, and research/IND) requires — and what falls outside the law.
7 min read
503A vs 503B for peptides: which compounding pathway fits?
The difference between 503A and 503B decides whether you can sell office stock, who can be the seller, and what you can compound. Here is the practical breakdown for peptides.
Get a free statement review — no obligation.
We review your processing statement and flag every risk indicator underwriters will ask about. Back to you within 24 hours.